140 related articles for article (PubMed ID: 12563687)
1. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroglu IC; Calgüneri M; Atalar E; Ozbalkan Z; Kirazli S; Celik I
J Rheumatol; 2003 Feb; 30(2):313-5. PubMed ID: 12563687
[TBL] [Abstract][Full Text] [Related]
2. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
3. Esophageal motor function in Familial Mediterranean Fever: a prospective evaluation of motility in 31 patients.
Bektaş M; Doğanay B; Alkan M; Ustun Y; Soykan I
Eur J Intern Med; 2009 Sep; 20(5):548-50. PubMed ID: 19712864
[TBL] [Abstract][Full Text] [Related]
4. Th1 polarization in familial Mediterranean fever.
Aypar E; Ozen S; Okur H; Kutluk T; Besbas N; Bakkaloglu A
J Rheumatol; 2003 Sep; 30(9):2011-3. PubMed ID: 12966607
[TBL] [Abstract][Full Text] [Related]
5. Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatment.
Pignataro L; Arisi E; Sambataro G; Corsi MM
J Surg Oncol; 2003 Jun; 83(2):112-5. PubMed ID: 12772205
[TBL] [Abstract][Full Text] [Related]
6. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
[TBL] [Abstract][Full Text] [Related]
7. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.
Tagami A; Ohnishi H; Hughes RD
Hepatogastroenterology; 2003; 50(51):742-5. PubMed ID: 12828076
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble fas level as a prognostic factor in patients with gynecological malignancies.
Konno R; Takano T; Sato S; Yajima A
Clin Cancer Res; 2000 Sep; 6(9):3576-80. PubMed ID: 10999747
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
10. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
Onalan G; Selam B; Baran Y; Cincik M; Onalan R; Gündüz U; Ural AU; Pabuccu R
Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
[TBL] [Abstract][Full Text] [Related]
11. Soluble Fas and soluble Fas L levels in patients with acute pancreatitis.
Endo S; Inoue Y; Fujino Y; Yamada Y; Sato N; Wakabayashi G; Sakamoto T; Ishikura H; Tanaka T; Inada K; Sato S
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):179-86. PubMed ID: 11913710
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients.
Deveci K; Gokakin AK; Senel S; Deveci H; Uslu AU; Sancakdar E
Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):253-60. PubMed ID: 23377817
[TBL] [Abstract][Full Text] [Related]
13. Increased serum concentrations of homocysteine and lipoprotein (a) in familial Mediterranean fever.
Karatay S; Yildirim K; Uyanik A; Uzkeser H; Kiziltunc A; Ugur M; Baygutalp F; Acemoglu H
Ann Clin Lab Sci; 2010; 40(1):10-4. PubMed ID: 20124324
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the Fas system in liver allograft rejection.
Rivero M; Crespo J; Mayorga M; Fábrega E; Casafont F; Pons-Romero F
Am J Gastroenterol; 2002 Jun; 97(6):1501-6. PubMed ID: 12094873
[TBL] [Abstract][Full Text] [Related]
15. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
16. The immune system in familial Mediterranean fever.
Melamed I; Shemer Y; Zakuth V; Tzehoval E; Pras M; Spirer Z
Clin Exp Immunol; 1983 Sep; 53(3):659-62. PubMed ID: 6225577
[TBL] [Abstract][Full Text] [Related]
17. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever.
Kisacik B; Akdogan A; Yilmaz G; Karadag O; Yilmaz FM; Koklu S; Yuksel O; Ertenli AI; Kiraz S
Eur J Intern Med; 2009 Jan; 20(1):44-7. PubMed ID: 19237091
[TBL] [Abstract][Full Text] [Related]
18. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
Nadir H; Unver S; Ozel AM; Yazgan Y; Gultepe M; Evrenkaya TR; Demirturk L; Gurbuz AK
Ren Fail; 2007; 29(1):73-7. PubMed ID: 17365913
[TBL] [Abstract][Full Text] [Related]
19. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease.
Ozel Demiralp D; Ekim M; Akar N
Clin Appl Thromb Hemost; 2009; 15(4):443-7. PubMed ID: 19033264
[TBL] [Abstract][Full Text] [Related]
20. QT variability in amyloidosis of familial Mediterranean fever.
Nussinovitch U; Ben-Zvi I; Livneh A
Isr Med Assoc J; 2012 Apr; 14(4):225-8. PubMed ID: 22675838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
